Phil Bergman Email & Phone Number

Billerica, Massachusetts, United States

Technical Applications Scientist, 2012 – PresentProvided internal and customer technical support and training for RNAi, RNA/DNA sample prep, cloning, transfection, protein analysis, and animal health and food safety products from the Life Technologies portfolio via phone, e-mail, chat, and video. • Contributed as one of three North American representatives in the creation of the global customer experience training program held in Darmstadt Germany.• Authored and edited product manuals, technical documents, web content, and other customer facing scientific information.• Collaborated with marketing and R&D to provide guidance on web content and website configuration specifically related to RNAi to increase visibility and sales.• Recognized in 2013 as the top North American technical support agent for customer satisfaction in relation to our customer survey (NPS).• Awarded honor of distinction for highest quality sales opportunities for year 2013.

Biomedical Engineer Senior, 2010 – 2012Developed high throughput in vitro assays for detection of mTOR pathway components from mouse tissue samples. Collaborated with biology of aging scientists to investigate the effects of rapamycin administration in mouse and marmoset in vivo models. • In Press publication as a contributing author in the Journal of Gerontology.• Assisted in the tutoring and training of graduate students.

Scientific Technical Leader I, 2009 – 2010Increased leadership role involving the analysis of mammalian macroautophagy, mTOR, and PI3k pathways with specific emphasis on assay development and target ID.• Co-led drosophila RNAi screen to identify modulators of mTOR independent of rapamycin.• Advanced various mTOR related assays to the high throughput screening group.• Continued work on autophagy flux which led to publications in Molecular Cell and Methods in Molecular Biology in 2011.Scientist II, 2007 – 2009Revealed mechanism by which L-glutamine uptake and rapid efflux regulates protein translation and autophagy. Collaborated across various departments to progress projects into proof of concept, developed novel assays, initiated high throughput screens, and validated targets.• First author publication in the journal Cell.• Received Catalyst Award for scientific achievement.• Collaborated on 2 million compound autophagy flux screen.Scientist I, 2005 – 2007Constructed and optimized cell based assays for studying mammalian macroautophagy, PI3K, and mTOR. Validated reporter cell lines using RNAi and tool compounds against specific pathway components. • Authored initial documents used as the NIBR wide model for high content analysis screens.• Developed autophagy flux assay, ribosomal protein S6 assay, and FYVE domain assay for the examination of the mTOR, PI3K, and autophagy pathways.

Senior Scientist, 2003 – 2005Conducted independent research on the construction of a novel vector system for the development of mammalian cell clones for high-level protein production. Collaborated with engineers on the development of small volume mammalian cell culture vessels designed to improve process development methodology for the production of bio-therapeutics.• Patent application for performing fed-batch operations in small volume reactors.

Seattle, Wa

Scientist III, 2001 – 2003Performed independent and cooperative research involving construction, expression, and purification of cytokine-polymer fusion proteins to be used as bio-therapeutics.• Patent application for the recombinant production of polyanionic polymers.Scientist II, 1999 – 2001Pioneered the development and purification scheme of recombinant bio-polymers of defined molecular weights of poly-glutamic acids to be used for therapeutic delivery.• Received E. Donnell Thomas Award for scientific achievement.• Established large-scale purification method for recombinant bio-polymers.